CNS Co (4076) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
22 Jul, 2026Executive summary
Revenue increased 11.1% year-over-year to ¥6,657 million, with operating profit up 10.9% and net income attributable to shareholders rising 6.5%.
Growth was driven by strong demand for DX solutions, new consulting business, and expanded digital transformation offerings.
Strategic focus included strengthening business foundations, expanding customer base, and enhancing solution offerings.
Financial highlights
Operating profit reached ¥619 million (up 10.9% year-over-year), and ordinary profit was ¥650 million (up 10.6%).
Net income attributable to shareholders was ¥461 million, up 6.5% from the previous year.
Total assets increased to ¥4,933 million, and equity ratio improved to 74.4%.
Cash and equivalents at year-end were ¥2,933 million, up ¥350 million from the prior year.
Dividend per share for the year was ¥48, with a payout ratio of 30.2%.
Outlook and guidance
FY2025 guidance: revenue ¥7,562 million (+13.6%), operating profit ¥660 million (+6.6%), net income ¥489 million (+6.2%).
Strategic investments in employee compensation and innovation expected to moderate profit growth.
New mid-term plan targets ¥10 billion revenue and 10%+ operating margin by FY2027.
Latest events from CNS Co
- Profit dropped sharply in Q1 FY2025 despite stable revenue, as labor costs surged.4076
Q1 202522 Jul 2026 - Revenue up 2.0% YoY, but profit down on higher costs; full-year outlook maintained.4076
Q2 202522 Jul 2026 - Revenue up 4.1% year-over-year, but profit margins declined on higher personnel costs.4076
Q3 202522 Jul 2026 - Revenue up 5.2% year-over-year, but profit margins declined amid higher costs and investments.4076
Q4 202522 Jul 2026 - Q1 FY2026 delivered double-digit profit growth, with all segments contributing to higher earnings.4076
Q1 202622 Jul 2026 - Revenue and profits surged on robust DX/AI demand, prompting an upward revision to full-year guidance.4076
Q2 202622 Jul 2026 - Strong revenue and profit growth driven by DX/AI demand, with upwardly revised full-year outlook.4076
Q3 202622 Jul 2026 - Strong revenue and profit growth driven by DX/AI, with double-digit gains and robust FY2027 outlook.4076
Q4 202622 Jul 2026